UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 387

Sortiert nach

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

Journal of clinical oncology, 2010-07, Vol.28 (19), p.3107-3114

2010

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer

Journal of clinical oncology, 2015-02, Vol.33 (5), p.433-441

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of maintenance bevacizumab (Bev) plus pemetrexed (Pem) after first-line cisplatin/Pem/Bev in advanced nonsquamous non-small cell lung cancer (nsNSCLC) on overall survival (OS) of patients (pts) on the AVAPERL (MO22089) phase III randomized trial

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8014-8014

2013

Link zum Volltext

Verfügbarkeit prüfen

Results of observational study of docetaxel, platinum compounds, 5-fluorouracil and leucovorin as first-line therapy in advanced gastric cancer (AGC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e15156-e15156

2013

Link zum Volltext

Verfügbarkeit prüfen

Some characteristics of invasive candidiasis pathogens

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e14084-e14084

2017

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy of ovarian cancer patients with metastases in the brain

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e13027-e13027

2014

Link zum Volltext

Verfügbarkeit prüfen

Estimating the impact of reducing the age of colorectal cancer screening on cancer incidence, mortality, and costs in Canada using OncoSim

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3526-3526

2022

Link zum Volltext

Verfügbarkeit prüfen

Platinum-based combinations as first-line chemotherapy in advanced, persistent, or recurrent cervical cancer

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15543-e15543

2012

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for patients with brain metastases from melanoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e19012-e19012

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcome according to tumor HER2 status and EGFR expression in advanced gastric cancer patients from the EXPAND study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.4021-4021

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II open-label study of mFOLFOX6 in combination with linifanib or bevacizumab for metastatic colorectal cancer

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.3532-3532

2012

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous NSCLC

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.7512-7512

2012

Link zum Volltext

Verfügbarkeit prüfen

Treatment of glioblastoma in Venezuela: Limitations using the current standard of care

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e13036-e13036

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1227-1234

2009

Link zum Volltext

Verfügbarkeit prüfen

Management of Metastatic Hormone-Sensitive Prostate Cancer: Is Docetaxel Needed?

Journal of clinical oncology, 2022-11, Vol.40 (31), p.3573-3575

2022

Link zum Volltext

Verfügbarkeit prüfen

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

Journal of clinical oncology, 2011-09, Vol.29 (25), p.3366-3373

2011

Link zum Volltext

Verfügbarkeit prüfen

Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial

Journal of clinical oncology, 2014-12, Vol.32 (36), p.4120-4126

2014

Link zum Volltext

Verfügbarkeit prüfen

Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4491-4497

2011

Link zum Volltext

Verfügbarkeit prüfen

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

Journal of clinical oncology, 2008-02, Vol.26 (4), p.527-534

2008

Link zum Volltext

Verfügbarkeit prüfen

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2055-2062

2012

Link zum Volltext

Verfügbarkeit prüfen

Pointed Progress in Second-Line Advanced Non-Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1676-1688

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 387

Suche als RSS-Feed

Aktive Filter

PublikationsformBuchkapitel

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(387)
Mit Volltextzugriff
(387)

Publikationsform

Artikel
(387)

Sprache

Englisch
(387)
Japanisch
(29)
Russisch
(8)

Erscheinungsjahr

n.n

Thema

Oncology
(95)
Life Sciences & Biomedicine
(89)
Science & Technology
(89)
Humans
(88)
Female
(66)
Middle Aged
(60)
Aged
(51)
Adult
(50)
Male
(49)
Biological And Medical Sciences
(45)
Medical Sciences
(45)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(37)
Tumors
(32)
Treatment Outcome
(30)
Cancer Research
(29)
Aged, 80 And Over
(22)
Breast Neoplasms - Drug Therapy
(19)
Lung Neoplasms - Drug Therapy
(16)
Original Reports
(16)
Prognosis
(16)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer

Effect of maintenance bevacizumab (Bev) plus pemetrexed (Pem) after first-line cisplatin/Pem/Bev in advanced nonsquamous non-small cell lung cancer (nsNSCLC) on overall survival (OS) of patients (pts) on the AVAPERL (MO22089) phase III randomized trial

Results of observational study of docetaxel, platinum compounds, 5-fluorouracil and leucovorin as first-line therapy in advanced gastric cancer (AGC)

Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Some characteristics of invasive candidiasis pathogens

Chemotherapy of ovarian cancer patients with metastases in the brain

Estimating the impact of reducing the age of colorectal cancer screening on cancer incidence, mortality, and costs in Canada using OncoSim

Platinum-based combinations as first-line chemotherapy in advanced, persistent, or recurrent cervical cancer

Chemotherapy for patients with brain metastases from melanoma

Clinical outcome according to tumor HER2 status and EGFR expression in advanced gastric cancer patients from the EXPAND study

Randomized phase II open-label study of mFOLFOX6 in combination with linifanib or bevacizumab for metastatic colorectal cancer

Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous NSCLC

Treatment of glioblastoma in Venezuela: Limitations using the current standard of care

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

Management of Metastatic Hormone-Sensitive Prostate Cancer: Is Docetaxel Needed?

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)

Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial

Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

Pointed Progress in Second-Line Advanced Non-Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition

Aktive Filter

Suchergebnisse filtern